MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
544.94M
P/E Ratio
N/A
Total Cash
423.85M
Projected Growth
N/A
Total Debt
11.86M
Revenue
47.4M
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
6.75
Total Debt/Equity
N/A
Revenue/Share
1.14 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)
Annualized Return+19%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SAGE
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com